PubRank

J Benitez

Author PubWeight™ 57.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet 2001 2.50
2 Rare mutations in XRCC2 increase the risk of breast cancer. Am J Hum Genet 2012 2.06
3 Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet 2000 1.72
4 Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet 1998 1.61
5 Localization of an autosomal dominant retinitis pigmentosa gene to chromosome 7q. Nat Genet 1993 1.55
6 A prospective study of bidirectional endoscopy (colonoscopy and upper endoscopy) in the evaluation of patients with occult gastrointestinal bleeding. Am J Gastroenterol 1992 1.29
7 Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proc Natl Acad Sci U S A 2002 1.23
8 MLH1 germline epimutations in selected patients with early-onset non-polyposis colorectal cancer. Clin Genet 2007 1.17
9 Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test. Br J Clin Pharmacol 1994 1.11
10 Assessment of the debrisoquin and dextromethorphan phenotyping tests by gaussian mixture distributions analysis. Clin Pharmacol Ther 1989 1.05
11 Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene 2006 1.04
12 Parental origin of chromosomal nondisjunction in a 49,XXXXY male using recombinant-DNA techniques. Clin Genet 1989 0.96
13 CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine. Br J Clin Pharmacol 1996 0.96
14 Hypermethylation of a 5' CpG island of p16 is a frequent event in non-Hodgkin's lymphoma. Leukemia 1997 0.95
15 Chromosomal patterns in human malignant astrocytomas. Cancer Genet Cytogenet 1987 0.93
16 Familial clustering and genetic heterogeneity in Meniere's disease. Clin Genet 2013 0.92
17 Genetic and epigenetic profile of sporadic pheochromocytomas. J Med Genet 2004 0.90
18 The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Br J Cancer 2009 0.90
19 Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients--relationship to the debrisoquine hydroxylation metabolic ratio. Br J Clin Pharmacol 1985 0.90
20 Victimization of patients with schizophrenia and related disorders. Aust N Z J Psychiatry 2005 0.89
21 Functional analysis of pAL5000 plasmid in Mycobacterium fortuitum. Plasmid 1992 0.88
22 Novel rhodopsin mutation in an autosomal dominant retinitis pigmentosa family: phenotypic variation in both heterozygote and homozygote Val137Met mutant patients. Hum Genet 1996 0.88
23 The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features. Breast Cancer Res Treat 2009 0.88
24 Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium. Genes Chromosomes Cancer 1999 0.87
25 Study of the parental origin of sexual aneuploidy in ten families using RFLPs. Ann Genet 1990 0.87
26 The detection of B-cell monoclonal populations by polymerase chain reaction: accuracy of approach and application in gastric endoscopic biopsy specimens. Hum Pathol 1993 0.87
27 Genetic instability of microsatellites in hematological neoplasms. Leukemia 1995 0.86
28 N-acetyltransferase 2 polymorphism is not related to the risk of advanced alcoholic liver disease. Scand J Gastroenterol 2002 0.85
29 Debrisoquine oxidation phenotype during neuroleptic monotherapy. Eur J Clin Pharmacol 1991 0.85
30 Analysis of midazolam and metabolites in plasma by high-performance liquid chromatography: probe of CYP3A. Ther Drug Monit 1998 0.84
31 Impact of chemotherapy on telomere length in sporadic and familial breast cancer patients. Breast Cancer Res Treat 2014 0.84
32 Homozygous myotonic dystrophy: clinical and molecular studies of three unrelated cases. J Med Genet 1996 0.84
33 Homozygosity for a Robertsonian translocation (13q14q) in three offspring of heterozygous parents. Cytogenet Cell Genet 1984 0.84
34 Admixture estimates for the population of Havana City. Ann Hum Biol 2009 0.84
35 Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine. Ther Drug Monit 2000 0.83
36 Correlation between mutations in p53 gene and protein expression in human lymphomas. Am J Hematol 1997 0.83
37 Frequency of constitutional chromosome alterations in patients with hematologic neoplasias. Cancer Genet Cytogenet 1987 0.82
38 Hypermethylation of p15/ink4b/MTS2 gene is differentially implicated among non-Hodgkin's lymphomas. Leukemia 1998 0.80
39 Autosomal dominant retinitis pigmentosa (adRP): exclusion of a gene from three mapped loci provides evidence for the existence of a fourth locus. Hum Mol Genet 1992 0.80
40 Non-toxic type 2 ribosome-inactivating proteins (RIPs) from Sambucus: occurrence, cellular and molecular activities and potential uses. Cell Mol Biol (Noisy-le-grand) 2003 0.80
41 Purinergic signaling and energy homeostasis in psychiatric disorders. Curr Mol Med 2015 0.79
42 An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers. Br J Cancer 2008 0.79
43 Acetylator polymorphism in Parkinson's disease. Eur J Clin Pharmacol 1989 0.78
44 Delta F508 gene deletion and prenatal diagnosis of cystic fibrosis in Italian and Spanish families. Prenat Diagn 1990 0.78
45 Autopsies on two native American Mummies. Am J Phys Anthropol 1980 0.78
46 Genome-wide linkage analysis and tumoral characterization reveal heterogeneity in familial colorectal cancer type X. J Gastroenterol 2014 0.78
47 Establishment and characterization of a new human colon adenocarcinoma cell line: BCS-TC2. Cytotechnology 1990 0.78
48 Cytogenetic studies in 18 patients with secondary blood disorders. Cancer Genet Cytogenet 1986 0.78
49 Activation of D1 receptors stimulates accumulation of gamma-aminobutyric acid in slices of the pars reticulata of 6-hydroxydopamine-lesioned rats. Neurosci Lett 1992 0.78
50 Analysis of the INK4a/ARF locus in non-Hodgkin's lymphomas using two new internal microsatellite markers. Leukemia 1999 0.78
51 Debrisoquine oxidation in schizophrenic patients treated with neuroleptics. Pharmacol Res Commun 1988 0.77
52 European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics Consortium. Br J Cancer 1999 0.77
53 Effect of pentobarbital on the reactivity of isolated human cerebral arteries. J Neurosurg 1981 0.77
54 Genetic services in Spain. Eur J Hum Genet 1997 0.77
55 Mapping of human chromosome 22 by in situ hybridization. Genomics 1990 0.77
56 Hybridization of Saccharomyces cerevisiae with Candida utilis through protoplast fusion. Curr Genet 1984 0.76
57 Cryopreservation of human skin with propane-1,2-diol. Cryobiology 1996 0.76
58 Allelic losses and genetic instabilities of PTEN and p73 in non-Hodgkin lymphomas. Leukemia 2000 0.76
59 Debrisoquine oxidation polymorphism in patients with rheumatoid arthritis. Ann Rheum Dis 1994 0.75
60 [Interaction between prajmaline and metoprotol: a possible pharmacogenetic explanation]. Orv Hetil 1997 0.75
61 Translocation of a supernumerary Y to a 15: study of six cases (three males and three females) in three generations. Hum Genet 1979 0.75
62 Polymorphic variations in peripherin-RDS gene in the Spanish population. Ann Genet 1995 0.75
63 Leukemic transformation in patients with the 5q- alteration: analysis of the behavior of the 5q- clones in preleukemic to leukemic phases. Cancer Genet Cytogenet 1987 0.75
64 [Variability of cytogenetic results obtained with the direct method and short-term cultures in 32 patients with various hematological disorders]. Sangre (Barc) 1983 0.75
65 Mutations in the yeast fructose 1,6-biphosphatase structural gene affect expression of a fructose 1,6-biphosphatase-endoglucanase A hybrid protein. Curr Genet 1993 0.75
66 [Myelodysplastic syndromes. Hematologic phenotypes, cytogenetic expression and clinical course in 133 cases (1979-1989)]. Sangre (Barc) 1990 0.75
67 Huntington's disease: a multidisciplinary study. Eur J Neurol 1995 0.75
68 Effect of pentobarbital on the contraction and calcium movements in cat cerebral and peripheral arteries. Brain Res 1987 0.75
69 Debrisoquine oxidation in an Italian population: a study in healthy subjects and in schizophrenic patients. Pharmacol Res 1992 0.75
70 Possible correlation between a specific alteration t(7;14) and the rearrangement of TCR observed in a Sézary's syndrome. Cancer Genet Cytogenet 1990 0.75
71 Cerebrospinal fluid homovanillic acid is reduced in untreated Huntington's disease. Clin Neuropharmacol 1995 0.75
72 Measurement of excitation functions for the (nat)Mo(d,x)⁹⁹Mo and (nat)Mo(p,x)⁹⁹Mo reactions. Appl Radiat Isot 2011 0.75
73 Angiotensin II facilitates tricyclic antidepressant-induced changes in QRS-duration in the rat. J Toxicol Clin Toxicol 1992 0.75
74 Cytogenetic and molecular studies of siblings with ataxia telangiectasia followed for 7 years. Cancer Genet Cytogenet 1997 0.75
75 Serial cytogenetic study of a human glioma cell line. Cancer Genet Cytogenet 1983 0.75
76 [Obstructive uropathy in genital prolapse]. Actas Urol Esp 1991 0.75
77 Two fertile Turner women in a family. Clin Genet 1984 0.75
78 Clinical pharmacological evaluation of an assay kit for intoxications with tricyclic antidepressants. Ther Drug Monit 1986 0.75
79 Endoglucanase A gene fusion vectors for monitoring protein secretion and glycosylation in yeast. Anal Biochem 1991 0.75
80 Linkage disequilibrium between cystic fibrosis locus and three DNA markers, XV-2c, KM19 and MP6d-9, in 43 Spanish families. Hum Genet 1990 0.75
81 Prognostic value of complex karyotypes in patients with simple refractory anemia. Cancer Genet Cytogenet 1991 0.75
82 Ph-positive chronic myeloid leukemia in a child. Rearrangement of the breakpoint cluster region. Cancer Genet Cytogenet 1990 0.75
83 bcr breakpoint location in Spanish patients with chronic myelogenous leukemia. Cancer Genet Cytogenet 1992 0.75
84 REM sleep rebound during withdrawal from chronic amphetamine administration is blocked by chloramphenicol. Neurosci Lett 1977 0.75
85 Drug information services at Eli Lilly and Company. Am J Hosp Pharm 1990 0.75
86 Chromosome banding patterns in patients with chronic myelocytic leukemia. Cancer Genet Cytogenet 1982 0.75
87 A multiparametric study of malignant lymphoma of mucosa associated lymphoid tissue (MALT). Leuk Lymphoma 1992 0.75
88 A point mutation changes the polymorphisms pattern in a cystic fibrosis carrier family. Hum Genet 1992 0.75
89 C-band pattern in patients with nervous system tumors. Cancer Genet Cytogenet 1987 0.75
90 Hypermethylation of P16ink4a and P15ink4b genes as a marker of disease in the follow-up of non-Hodgkin's lymphomas. Br J Haematol 2000 0.75
91 Cytogenetic study of B-cell lymphoma of mucosa-associated lymphoid tissue. Cancer Genet Cytogenet 1992 0.75
92 Recurrence of Down's syndrome associated with microchromosome. Hum Genet 1979 0.75
93 [Ultrasonic diagnosis of prostatic adenocarcinoma. Prospective study of a sample of 159 patients]. Actas Urol Esp 1989 0.75
94 Trisomy 14 in a case of sideroblastic refractory anemia. Cancer Genet Cytogenet 1994 0.75